Some of Nader’s main comments: * Company is i
Post# of 148161
(Total Views: 786)
Posted On: 11/23/2020 6:14:41 AM
Some of Nader’s main comments:
* Company is in full swing to obtain full enrollment in the Phase 3 COVID-19 trial before year end
* initiate our Phase 2 trial for COVID-19 patients with multiple long-hauler symptoms and perhaps complete enrollment in 4-6 weeks
* about to enroll its first patient in the NASH trial this month
* hopeful the DSMC can complete their second interim analysis as quickly as possible
* Company is in full swing to obtain full enrollment in the Phase 3 COVID-19 trial before year end
* initiate our Phase 2 trial for COVID-19 patients with multiple long-hauler symptoms and perhaps complete enrollment in 4-6 weeks
* about to enroll its first patient in the NASH trial this month
* hopeful the DSMC can complete their second interim analysis as quickly as possible
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼